Skip to content

Screener

Eligibility screening

NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Sponsored by Nurix Therapeutics, Inc.Study detailsClinicalTrials.gov

18 US sites in CA, CO, CT, FL +10

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.